Connect with us

Health

Surprising discovery reveals new target for aggressive lung adenocarcinoma – News-Medical.Net

Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.

Published

on

Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer. These drugs inhibit cancer cells by thwarting the molecular changes that drive them to grow while largely sparing healthy tissues. But for the other two-thirds of people with this type of cancer, there are fewer treatment options.
A team from Memorial Sloan Kettering is reporting new findings about a particularly aggressive subset of lung adenocarcinomas that are…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending